Principles of alemtuzumab immunoablation in hematopoietic cell transplantation for non-malignant diseases in children: A review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Principles of alemtuzumab immunoablation in hematopoietic cell transplantation for non-malignant diseases in children: A review

Published:2018-01-19 Issue:2 Volume:22 Page:e13142
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatr Transplantation

Author:

Guilcher Gregory M. T.¹^ORCID,Shah Ravi²,Shenoy Shalini³

Affiliation:

1. Section of Paediatric Oncology/BMT; Departments of Oncology and Paediatrics; University of Calgary; Calgary AB Canada

2. Department of Paediatric Haematology/BMT; Great Ormond Street Hospital; NHS Foundation Trust; London UK

3. Division of Pediatric Hematology/Oncology; Washington University School of Medicine; St. Louis MO USA

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/petr.13142/fullpdf

Reference113 articles.

1. Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement;Hale;Blood,1983

2. Alemtuzumab;Frampton;Drugs,2003

3. Alemtuzumab for the prevention and treatment of graft-versus-host disease;Kanda;Int J Hematol,2011

4. In vivo T-cell depletion using alemtuzumab in family and unrelated donor transplantation for pediatric non-malignant disease achieves engraftment with low incidence of graft vs. host disease;Saif;Pediatr Transplant,2015

5. The effects of CAMPATH-1H on cell viability do not correlate to the CD52 density on the cell surface;Lee;PLoS One,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity;Journal of Clinical Immunology;2024-05-22

2. Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC study;Blood Advances;2023-08-11

3. Are homeostatic mechanisms aiding the reconstitution of the T-cell pool during lymphopenia in humans?;Frontiers in Immunology;2022-11-22

4. Antibody-mediated cell depletion therapies in multiple sclerosis;Frontiers in Immunology;2022-09-12

5. Alemtuzumab clearance, lymphocyte count, and T‐cell chimerism after hematopoietic stem cell transplant in sickle cell disease;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2021-11-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3